Medindia LOGIN REGISTER
Medindia
Advertisement

Virus Hero To Battle Superbugs

by Ann Samuel on August 15, 2007 at 1:05 PM
Virus  Hero To Battle Superbugs

Scientists are investigating a type of "good" virus that infects and kills many types of harmful bacteria as a part of their fight against antibiotic-resistant superbugs, such as MRSA.

They have developed a cream containing the viruses, known as bacteriophages, to eliminate hospital-acquired infections. The product may be available in the markets within three years.

Advertisement

Steps are being taken to develop similar treatments for bacterial ear infections and food poisoning, which are triggered by the most stubbornly resistant bugs.

The West has neglected the viruses for more than six decades, despite the fact that they have been used in the former Soviet Union and Eastern Europe to treat infections since the 1920s.
Advertisement

It is now being re-examined whether phage therapies, previously considered to have been superceded by antibiotics, can curb overuse of the drugs.

The scientists are planning to conduct clinical trials of the proposed cream next year, after laboratory tests in which phages have wiped out more than 15 strains of the superbug.

The anti-MRSA cream could be applied to the inside of the nose, where bacteria are known to thrive. It is likely to contain a "cocktail" of three or four types of virus so that it is difficult for the bugs to build up resistance to it.

Nick Housby, Chief Executive of the Coventry-based biotech company Novolytics that is carrying out the research, said that the aim was to use the phage cream as a preventative measure that could be given to staff and patients a day or two before they went into hospital.

He also said that the cream could eliminate infections in affected patients within 24 hours.

"We're extremely optimistic. We know we can kill, in the laboratory, clinically relevant strains. It's a question now of putting it into the right cream, in terms of the formulation, to make sure that it works," Timesonline quoted him as saying.

With virus therapy now returning to the West, more than 12 companies are developing phage products.

"We're now finding antibiotics are becoming less useful. The climate is probably right to revisit bacteriophage therapy," Geoff Hanlon, an expert in the viruses at the University of Brighton, said.

Source: ANI
ANN
Font : A-A+

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Research News

South Korea's 2050 Forecast: Negative Growth Amid Low Fertility
South Korea's total fertility rate, averaging the number of children a woman aged 15-49 has in her lifetime, dropped to 0.81.
New Immunotherapy for Psoriasis & Vitiligo
Scientists identified mechanisms governing immune cells, selectively removing troublemakers to reshape skin immunity. Benefits those with psoriasis, vitiligo.
2050 Forecast: 1.06 Billion Individuals to Face 'Other' Musculoskeletal Disorders
By 2050, an anticipated increase from 494 million cases in 2020 to 1.06 billion people with musculoskeletal disabilities is expected.
Gene Therapies Can Disrupt Gaucher Disease Drug Market
Experts consulted by GlobalData anticipate a significant overhaul in the Gaucher disease scenario because of forthcoming gene therapies in development.
NASH Cases Expected to Hit 26.55 Million in 7MM by 2032
Within the seven major markets, 12% to 20% of diagnosed prevalent NASH cases present severe liver damage (stage 4 liver fibrosis), denoting cirrhosis.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Virus Hero To Battle Superbugs Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests